Press information
Amanda Bonello
GLP-1 patient advocate, ACE-certified health coach, and podcast host. I am available to speak with journalists about GLP-1 affordability and access, the patient experience, weight stigma, self-advocacy, and the ways policy decisions affect people using these medications.
Short bio
Amanda Bonello is an ACE-certified health coach with a specialization in weight management and advanced training in anti-obesity medications. She is a GLP-1 patient and patient advocate, host of the GLP-1 Studio Podcast, creator of the STRONG Framework for Self-Advocacy, and founder of the separate GLP-1 Collective nonprofit.
Press contact
Use the press inquiry form at the bottom of this page.
For a deadline-sensitive request, include the deadline and preferred interview format in your message. I will reply as quickly as I can.
Available for print and online interviews, radio, podcasts, documentary interviews, and on-camera conversations by appointment.
Long bio
Amanda Bonello is a GLP-1 patient, patient advocate, and ACE-certified health coach based in Marion, Iowa. She has a specialization in weight management and advanced training in anti-obesity medications. Amanda began taking a GLP-1 medication in October 2024. The following month, she started a petition calling for affordable access to GLP-1 medications. More than 27,000 people signed it. She has since submitted comments and letters to federal agencies about access, compounding, and patent concerns.
Her patient advocacy has been included in reporting by Reuters, Wired, The New York Times, Politico, USA Today, CNBC, Fast Company, and other news organizations. Amanda hosts the GLP-1 Studio Podcast, which features conversations with clinicians, researchers, advocates, and patients. She also founded the GLP-1 Collective, a separate nonprofit created for patient support, education, and advocacy against stigma.
She created the STRONG Framework for Self-Advocacy and developed GLP1Strong.com as a free patient resource. Her coaching practice, GLP1Coach, follows a compassionate care model and uses STRONG as the foundation of its coaching system.
Selected media coverage
Amanda has participated in reporting or provided patient connections for:
Nov 26, 2024
Politico Feature
Featured in Politico's Prescription Pulse newsletter on GLP-1 patient petitions to the FDA.
Dec 1, 2024
USA Today (first feature)
Quoted in USA Today on high prices prompting consumers to seek weight loss drug alternatives.
Dec 19, 2024
ABC Local 5 News Iowa
Featured on local news urging FDA to support GLP-1 compounding alternatives.
Dec 24, 2024
CNBC Coverage
Featured in CNBC coverage on FDA Zepbound shortage impact.
Mar 2, 2025
USA Today (second feature)
Featured covering FDA decisions on compounded GLP-1 medications.
Mar 12, 2025
Fast Company Feature
Quoted on the potential disappearance of compounded Wegovy and Zepbound under new FDA rules.
Apr 1, 2025
KRLD NewsRadio 1080
Featured on Audacy radio discussing FDA bans on compounded weight loss drugs.
May 14, 2025
Wired Magazine Feature
Featured in Wired on GLP-1 copycats and the compounded medication landscape.
May 23, 2025
Reuters Coverage
Featured in Reuters on the compounding crackdown and patients losing access to discounted medications.
Oct 20, 2025
Danish Broadcasting Corporation
Featured in Danish Broadcasting Corporation article on Novo Nordisk litigation and patient advocacy.
Nov 6, 2025
White House MFN Announcement
Real-time reaction filmed by Danish crew at ObesityWeek.
Feb 12, 2026
KXCR Community Radio Oregon
Featured in radio interview on GLP-1 advocacy.
Feb 23, 2026
New York Times
Facilitated direct patient connects for NY Times article on exercise and weight loss drugs.
Feb 23, 2026
Business Insider
Connected patients for interviews for Business Insider news report.
Interview topics
- · Affordable access to GLP-1 medications
- · The effect of coverage changes on patients
- · Compounded medication policy from a patient perspective
- · Weight stigma and patient communication
- · The STRONG Framework for Self-Advocacy
- · GLP-1 patient communities and support needs (for events, see the Speaking page)
Press inquiry
Tell me what you are covering and when you need a response.
Include your publication or program, deadline, and interview format.